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The aim of this study is to incorporate a physically correct 
description of the bladder properties in treatment planning, 
most notably the presence of convection and the absence of 
perfusion, and to assess the differences with the 
conventional model. 
 
Material and Methods: We created a convective 
thermophysical fluid model based on the Boussinesq 
approximation to the Navier-Stokes equations; this means we 
assumed all parameters to be temperature independent 
except for the mass density in the gravitational term. We 
implemented this using the (finite element) OpenFOAM 
toolkit, and coupled it to our (finite difference) in-house 
developed treatment planning system, based on Pennes’ bio-
heat equation. 
A CT scan was obtained from a bladder cancer patient and an 
experienced clinician delineated the bladder as part of the 
standard clinical work-flow. Based on this input, we first 
performed the treatment planning the conventional way with 
a muscle-like solid bladder, and calculated the optimal phase 
and amplitude settings for all four antennae. Next, we redid 
the temperature calculation with the expanded treatment 
planning system with a fluid-filled bladder, using the same 
settings. We subsequently calculated the differences 
between the two temperature distributions. 
 
Results: The temperature in the bladder with realistic fluid 
modelling is much higher than without, as the absence of 
perfusion in the bladder filling leads to a much lower heat 
removal. The maximum temperature difference was 3.6 °C. 
Clinically relevant tissue temperature differences of more 
than 0.5 °C extended to 1.75 cm around the bladder. The 
temperature distribution according to the convective model 
and the difference with the solid only model are shown in 
Figure 1. The difference reflects the homogenizing effect of 
convection within the bladder and the nett heat transport in 
the upward direction. 
 
 
 
Conclusion: The addition of the new convective model to the 
hyperthermia treatment planning system leads to clinically 
highly relevant temperature changes. Explicit modelling of 
fluids is particularly important when the bladder or its direct 
surroundings are part of the treatment target area. 
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Purpose or Objective: There have been concerns that the 
quality of highly conformal dose distributions, delivered 
under active MRI guidance, may be degraded by the influence 
of the magnetic field on secondary electrons. This planning 
study quantifies this effect for stereotactic body 
radiotherapy (SBRT) of lung tumors, conducted either with or 
without real-time multileaf collimator (MLC) tumor tracking. 
 
Material and Methods: The Elekta Monaco treatment 
planning software, research version 5.09.07, was used to 
design treatment plans on the peak-exhale 4DCT phase of 
nine patients undergoing lung SBRT. The software features a 
machine model of the Atlantic MR-linac system and allows 
dose calculation and plan optimization under consideration of 
a magnetic field. 
For each patient, we prepared four different 9-beam step-
and-shoot IMRT plans: two for conventional, non-tracked 
treatment and two for delivery with real-time MLC tumor 
tracking, each delivered either with or without a 1.5T 
magnetic field oriented in the superior-inferior patient 
direction. For the conventional delivery, the internal target 
volume was defined as the union of the gross tumour volumes 
(GTV), delineated on each 4DCT phase. For the tracked 
delivery, the moving target volume was defined as union of 
all GTVs, each corrected for the center-of-volume shift thus 
accounting for target deformations. Dose was prescribed 
according to the RTOG 1021 guideline. Delivery of the 
respective plans was simulated to all 4DCT phases and the 
doses were then deformably accumulated onto the peak-
exhale phase. 
In order to evaluate the effect of the magnetic field and real-
time tumor tracking, several dose-volume metrics and the 
integral deposited energy in the body were compared. 
Statistical significance of the differences was evaluated using 
a two-sided paired t-test after verifying normal distribution 
of them, while correcting for multiple testing for the four 
primary endpoints. 
 
Results: The table presents the differences in the 
investigated dose-volume metrics due to either the presence 
of a magnetic field or real-time MLC tumor tracking. Most 
prominently, the magnetic field caused an increase in dose to 
the skin and a decrease of dose to the GTV (see figure). 
While statistically significant, the magnitude of these 
differences is small. In all 36 simulated dose deliveries, the 
dose prescription to the target was fulfilled and there were 
only minor violations of normal tissue constraints.  
Real-time MLC tumor tracking was able to maintain dose 
coverage of the GTV while reducing the integral deposited 
energy. This results in a decrease in dose to the skin and 
normal lung tissue, both with and without a magnetic field. 
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Conclusion: This study has shown that accounting for the 
effects of the magnetic field during treatment planning 
allows for design of clinically acceptable lung SBRT 
treatments with a MR-linac. Furthermore, it was found that 
the ability of real-time tumor tracking to decrease dose 
exposure to healthy tissue was not degraded by a magnetic 
field. 
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Purpose or Objective: Combining the capabilities of high 
resolution soft tissue MR imaging and intensity modulated 
radiation therapy into a hybrid device has the potential to 
increase the accuracy of radiotherapy. However, it is known 
that the magnetic field of the MR manipulates the trajectory 
of the secondary electrons and leads to a deviation of dose 
especially at the interfaces between high and low density 
materials. This study aims to introduce a routine for the 
evaluation of magnetic field effects to dose delivery and plan 
optimization using Monte Carlo simulations. 
 
Material and Methods: An EGSnrc Monte Carlo environment, 
based on the egs++ class library, was developed which can be 
used for the simulation of IMRT treatment plans in the 
presence of a magnetic field, based on patient CT data. A 
routine for the processing of treatment planning parameters 
and Monte Carlo simulation data was implemented into the 
in-house open source treatment planning system matRad. In 
order to basically validate the implementation, dose 
distributions at 0 T were compared against collapsed cone 
calculations by the treatment planning system RayStation. 
The effect of a magnetic field to the dose distribution was 
investigated for simulations in a porcine lung phantom. Based 
on Monte Carlo simulations of patient specific beamlets, plan 
optimization was performed and analyzed.  
 
Results: Comparison showed that the Monte Carlo simulations 
of IMRT plans at 0 T are in good agreement with RayStation 
dose calculations. The effect of a 1.5 T lateral magnetic field 
on the dose distribution showed distinct alteration in tumor 
dose. Differences appear to be less when an opposing field 
technique is used. It could further be proven that the routine 
is capable of performing plan optimization based on Monte 
Carlo simulated beamlets in the presence of a magnetic field 
(see figure 1).  
 
Conclusion: A routine for dose calculation of IMRT plans with 
EGSnrc and for plan optimization based on Monte Carlo 
simulated beamlets using the in-house planning system 
matRad was developed. This implementation provides the 
possibility to analyze the effects of a magnetic field during 
radiotherapy in detail. Additionally it enables the 
investigation of optimization strategies for an MRI-LINAC 
system.  
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Purpose or Objective: High costs and limited capacity in 
proton therapy requires prioritizing according to expected 
benefit. The aim of this work is to quantify the clinical 
advantage of robust intensity-modulated proton therapy 
(IMPT) in terms of sparing of organs at risk (OARs) for three 
target volumes in treatment of gynaecological cancers 
compared with state-of-the-art intensity-modulated photon 
therapy (IMRT), and to evaluate for which target volume the 
benefit would justify the use of IMPT. 
 
Material and Methods: Three target volumes were included: 
pelvic region (primary or postoperative treatment; N=10, 6 
with boost dose), pelvic and para-aortic region (N=6, all with 
